Encompass Health Corp
General ticker "EHC" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $10.0B
Encompass Health Corp follows the US Stock Market performance with the rate: 63.4%.
Estimated limits based on current volatility of 1.0%: low 92.98$, high 94.90$
Factors to consider:
- Company pays dividends: last record date 2024-10-01, amount 0.17$ (Y0.72%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [62.04$, 90.04$]
- 2024-12-30 to 2025-12-30 estimated range: [71.54$, 101.97$]
Financial Metrics affecting the EHC estimates:
- Positive: Non-GAAP EPS, $ of 3.64 > 2.29
- Positive: Operating cash flow per share per price, % of 12.97 > 12.76
- Positive: 9.05 < Operating profit margin, % of 15.24
- Negative: Investing cash flow per share, $ of -6.06 <= -3.48
- Positive: Inventory ratio change, % of 0.70 <= 1.08
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 7.05
Short-term EHC quotes
Long-term EHC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5,121.60MM | $4,348.60MM | $4,801.20MM |
| Operating Expenses | $4,298.80MM | $3,720.70MM | $4,069.40MM |
| Operating Income | $822.80MM | $627.90MM | $731.80MM |
| Non-Operating Income | $-317.80MM | $-177.10MM | $-124.60MM |
| Interest Expense | $164.60MM | $175.70MM | $143.50MM |
| Income(Loss) | $505.00MM | $450.80MM | $607.20MM |
| Taxes | $101.90MM | $100.10MM | $132.20MM |
| Other Income(Loss) | $114.10MM | $15.20MM | $-12.00MM |
| Profit(Loss) | $517.20MM | $365.90MM | $463.00MM |
| Stockholders Equity | $1,911.30MM | $1,310.30MM | $1,647.50MM |
| Inventory | $65.10MM | $31.60MM | $0.00MM |
| Assets | $6,864.90MM | $5,636.50MM | $6,102.40MM |
| Operating Cash Flow | $715.80MM | $705.80MM | $850.80MM |
| Capital expenditure | $551.20MM | $584.10MM | $583.10MM |
| Investing Cash Flow | $-666.30MM | $-627.00MM | $-602.80MM |
| Financing Cash Flow | $-240.10MM | $-145.70MM | $-197.20MM |
| Earnings Per Share* | $4.15 | $2.72 | $3.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.